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Abstract
OBJECTIVE—To describe the prevalence of serious maternal complications following early 
preterm birth by gestational age (GA), delivery route and type of cesarean incision.
STUDY DESIGN—Trained personnel abstracted data from maternal and neonatal charts for all 
deliveries on randomly selected days representing 1/3 of deliveries across 25 US hospitals over 3 
years (n=115,502). All women delivering non-anomalous singletons between 23 and 33 weeks’ 
gestation were included. Women were excluded for antepartum stillbirth and highly morbid 
conditions for which route of delivery would not likely impact morbidity including non-reassuring 
fetal status, cord prolapse, placenta previa, placenta accreta, placental abruption, and severe, 
Corresponding author: Uma M. Reddy, MD, MPH, 6100 Executive Blvd. Rm 4B03F, Bethesda, MD 20892-7510, Phone: 
301-496-5575; Facsimile: 301-496-3790, reddyu@mail.nih.gov. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
The authors report no conflict of interest
Presentation: This study was presented in part at the 35th Annual Society of Maternal-Fetal Medicine Meeting (February 2015, San 
Diego, CA) as a poster presentation.
HHS Public Access
Author manuscript
Am J Obstet Gynecol. Author manuscript; available in PMC 2016 October 01.
Published in final edited form as:













unstable maternal conditions (cardiopulmonary collapse, acute respiratory distress syndrome, 
seizures). Serious maternal complications were defined as: hemorrhage (blood loss ≥1500 mL, 
blood transfusion, or hysterectomy for hemorrhage); infection (endometritis, wound dehiscence, or 
wound infection requiring antibiotics, reopening or unexpected procedure); ICU admission; or 
death. Delivery route was categorized as classical cesarean delivery (CCD), low transverse 
cesarean delivery (LTCD), low vertical cesarean delivery (LVCD), and vaginal delivery (VD). 
Association of delivery route with complications was estimated using multivariable regression 
models yielding adjusted relative risks (aRR) controlling for maternal age, race, body mass index, 
hypertension, diabetes, preterm premature rupture of membranes, preterm labor, GA, and hospital 
of delivery.
RESULTS—Of 2659 women who met criteria for inclusion in this analysis, 8.6% of women 
experienced serious maternal complications. Complications were associated with GA and were 
highest between 23–27 weeks of gestation. The frequency of complications was associated with 
delivery route; compared with 3.5% of SVD, 23.0% of CCD (aRR 3.54, 95%CI 2.29–5.48), 12.1% 
of LTCD (aRR 2.59, 95%CI 1.77–3.77), and 10.3% of LVCD (aRR 2.27, 95%CI 0.68–7.55) 
experienced complications. There was no significant difference in complication rates between 
CCD and LTCD (aRR 1.37, 95%CI 0.95–1.97) or between CCD and LVCD (aRR 1.56, 95%CI 
0.48–5.07).
CONCLUSION—The risk of maternal complications after early preterm delivery is substantial, 
particularly in women who undergo cesarean delivery. Obstetricians need to be prepared to 
manage potential hemorrhage, infection and ICU admission for early preterm births requiring 
cesarean delivery.
Keywords
maternal morbidity; early preterm delivery; classical cesarean delivery; hemorrhage; infection; 
ICU admission
INTRODUCTION
Improved neonatal survival has led to an increase in the number of cesarean deliveries being 
performed preterm, especially at the border of viability.1,2 Use of a vertical incision in the 
upper uterine segment is often required and is referred to as a classical cesarean delivery. 
Classical cesarean deliveries are usually performed for indications such as an inadequately 
formed or inaccessible lower segment and/or fetal malpresentation, conditions that occur 
more commonly in preterm pregnancies.
The increased neonatal morbidity with early preterm birth (23–33 weeks of gestation) is well 
described. However, there is a paucity of data on maternal morbidity associated with early 
preterm delivery and in fact this has been identified as a key area requiring further research.3 
Classical cesarean delivery has been associated with an increased risk of uterine rupture and 
uterine scar dehiscence in subsequent pregnancies4,5 and, in some studies, with an increased 
risk of acute complications such as hemorrhage and infection.6–10 Several mostly small 
studies have evaluated the relationship of preterm delivery (including variation across 
gestational age) and route of delivery to postpartum maternal morbidity.5,8,9,11 The data 
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comparing postoperative morbidity in classical versus low segment cesarean delivery in the 
early preterm period are also extremely limited.5,8,9,11 The objectives of this analysis were 
to determine the prevalence of serious maternal complications associated with early preterm 
delivery by gestational age (GA) and to determine rates of serious maternal complications 
by route of delivery (vaginal delivery (VD); classical cesarean delivery (CCD), low 
transverse cesarean delivery (LTCD) and low vertical cesarean delivery (LVCD) by using 
highly detailed data obtained by chart abstraction by trained research personnel.
MATERIALS AND METHODS
Between 2008 and 2011, investigators at 25 medical centers of the Eunice Kennedy Shriver 
National Institute of Child Health and Human Development Maternal-Fetal Medicine Units 
(MFMU) Network assembled an observational obstetric cohort (i.e., the Assessment of 
Perinatal EXcellence (APEX) study) that included detailed information on patient 
characteristics, intrapartum events, and pregnancy outcomes that was collected by trained 
and certified nurses. Patients eligible for data collection were those who delivered within the 
institution, were at least 23 weeks of gestation, had a live fetus on admission and delivered 
during the 24-hour period of randomly selected days representing one-third of deliveries 
over this 3-year period (hence approximating the number of deliveries in one year in the 
MFMU Network). Days were chosen via computer-generated random selection, stratified by 
weekdays, weekends and holidays and generated separately for each hospital. On selected 
days, the labor and delivery logbook at each participating center was screened to identify all 
eligible women. Data from maternal and neonatal charts for all eligible deliveries were 
abstracted as soon as the delivery and nursery medical records became available (n= 
115,502). Institutional review board approval for the study and a waiver of informed consent 
was obtained at all centers. Full details of the technique of data collection have been 
described previously.12
This secondary analysis included women delivering a non-anomalous singleton between 23 
weeks and 0 days and 33 weeks and 6 days of gestation. Women with an antepartum 
stillbirth and women who were admitted with non-reassuring fetal status, cord prolapse, 
placenta previa, placenta accreta, placental abruption, unstable and severe maternal 
condition (cardiopulmonary collapse, acute respiratory distress syndrome, seizures) were 
excluded from the main analysis due to the extremely high maternal morbidity associated 
with these indications for delivery by themselves and in order to understand the effect of the 
route of delivery on serious maternal postpartum complications. Serious maternal 
complications were defined as the occurrence of one of the following: hemorrhage (blood 
loss ≥1500 mL, blood transfusion, or hysterectomy for hemorrhage); infection (endometritis, 
wound dehiscence, or wound infection requiring antibiotics, reopening or unexpected 
procedure); ICU admission; or death.12
The delivery route was classified as vaginal delivery (VD), classical cesarean delivery 
(CCD), low transverse cesarean delivery (LTCD) and low vertical cesarean delivery 
(LVCD). Uterine incisions that were started as low segment incisions but were extended into 
the upper uterine segment - “J” or inverted “T” incisions -were included as part of the CCD 
group.
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Univariate analyses used the chi-square or Fisher’s exact test for categorical variables and 
the Wilcoxon rank-sum test for continuous variables. The association of delivery route 
(CCD, LTCD, LVCD, VD) with the occurrence of serious maternal complications was 
determined using multivariable log Poisson regression yielding adjusted relative risks (aRR) 
and 95% confidence intervals after controlling for maternal age, race, body mass index 
(kg/m2), hypertension (chronic, gestational or preeclampsia), diabetes (pregestational or 
gestational), preterm premature rupture of membranes (PPROM), preterm labor, gestational 
age (GA), and hospital. We also sought to describe the association between delivery route 
and maternal morbidity by categories of gestational age and conducted a post-hoc analysis 
that included a multivariable model with an interaction term between delivery route and 
gestational age. SAS software (SAS Institute, Cary, NC), was used for the analyses. All tests 
were two-tailed and p<.01 was used to define statistical significance to account for multiple 
univariate and multivariate analyses. No imputation for missing data was performed.
RESULTS
Of 3390 women delivering a non-anomalous singleton between 23 weeks and 0 days and 33 
weeks and 6 days of gestation, 712 women were excluded from the main analysis and 
evaluated separately due to the presence of the following: antepartum stillbirth (n=11); non-
reassuring fetal status or cord prolapse (n=374); an adverse placental condition (previa, 
accreta or abruption) (n=324); or an unstable and severe maternal condition on admission 
(n=3). An additional 19 were excluded because they were delivered by cesarean and had 
missing type of incision or were missing data regarding type of fetal presentation, leaving 
2659 women who are the subject of the main analysis. All 2659 women had complete data 
to define the outcomes of infection, ICU admission, and death; however, 63 women had 
missing data to define hemorrhage and 61 had missing data to define the composite of 
serious maternal complication. There were 272 women in the CCD group (248 with vertical 
incision in the upper uterine segment and 24 with T and J incisions), 904 women in the 
LTCD group and 29 women in the LVCD group.
Patient characteristics differed significantly by route of delivery. Women in the CCD, LTCD 
and LVCD groups had a higher BMI, were more likely to have had a prior cesarean delivery 
and hypertension, less likely to have PPROM and preterm labor, and more likely to have a 
non-vertex fetal presentation and a lower birth weight and small for gestational age neonate 
than the VD group, p< 0.01. (Table 1) Women in the CCD group were more likely to be 
black, less likely to have private insurance, more likely to have a non-vertex fetal 
presentation and a lower birth weight neonate, and deliver at an earlier gestational age than 
the LTCD group, p < 0.01. (Table 1)
Overall, 8.6% of women experienced a serious maternal complication. The composite of 
serious maternal complications also captured other serious outcomes such as disseminated 
intravascular coagulation (n=5), idiopathic thrombocytopenic purpura (n=1), 
cardiopulmonary arrest (n=1), cardiac dysfunction (n=8), adult respiratory distress (n=6), 
renal failure (n=2), sepsis (n=6) and hysterectomy (n=2) which were classified under ICU 
admission. The occurrence of serious maternal complications was associated with 
gestational age and highest in the earliest gestational age range (23–27 weeks of gestation). 
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The rate of CCD also was associated with gestational age and highest in the earliest 
gestational age range. (Table 2) The frequency of complications was associated with route 
of delivery, with 23.0% of those undergoing classical CD, 12.1% of those undergoing LTCD 
and 10.3% of those undergoing LVCD experiencing serious maternal complications 
compared with 3.5% of women delivering vaginally (p<0.001, Table 3). Hemorrhage, 
infection, and ICU admission also were increased among women undergoing CCD or LTCD 
compared with VD (p<0.001, Table 3). In multivariable analyses, CCD (aRR 3.54, 95%CI 
2.29–5.48) and LTCD (aRR 2.59, 95%CI 1.77–3.77) were associated with significantly 
more serious maternal complications than VD when adjusting for characteristics affecting 
maternal outcome (Table 4; bold indicates RRs significant at P<.01). There was no 
significant difference in serious maternal complications between CCD and LTCD (aRR 
1.37, 95%CI 0.95–1.97) or between CCD and LVCD (aRR 1.56, 95%CI 0.48–5.07).
Frequencies of serious maternal complications are summarized in the supplemental table on 
the cases who were excluded from the current analysis because of non-reassuring fetal 
status, cord prolapse or an adverse placental condition (previa, accreta or abruption).
COMMENT
In this study, using detailed recent data we found that 8.6% of women undergoing early 
preterm delivery experience serious maternal complications. The clinical implications of 
these findings are that the risk of maternal postpartum complications in early preterm 
delivery is substantial, particularly in women who undergo cesarean delivery. Of women 
undergoing classical cesarean delivery, 23.0% experienced serious maternal complications 
whereas the rate was 3.5% for women delivering vaginally. Given the effect on immediate 
maternal morbidity as well as increased risk associated with subsequent pregnancies, it is 
important that providers caring for women who deliver in the early preterm period be 
cognizant of these complications and be prepared to manage them.
Our results are similar to previous smaller case series of classical cesarean delivery. Greene 
et al. studied classical CD at a single institution in Ireland between 1983–1995 (35 preterm, 
27 term). There were no maternal deaths; 49% and 19% were complicated by infection and 
hemorrhage, respectively, and 2 women required hysterectomy.6 Bethune et al. studied a 
total of 123 classical CD at a single institution in Melbourne, Australia from 1986–1994. 
The incidence of CCD declined with increasing gestational age. At 24 weeks of gestation, 
20% of all cesarean deliveries were classical, decreasing to 5% by 30 weeks of gestation. 
Complications after classical CD were related to the indication for performing the CD and 
not specifically to the classical incision itself. For example, 5 women required a cesarean 
hysterectomy because of uncontrolled hemorrhage in association with placenta accreta (N = 
4) and uterine rupture (N = 1).7
Prior literature on this topic is limited, conflicting, and has included heterogeneous groups of 
women (term vs. preterm, placenta accreta/emergency CD) making it difficult to distinguish 
the association of the indications from delivery route in maternal outcomes. Blanco et al. 
compared 89 CCD matched to 89 LTCD between 1970 and 1977. The authors found no 
significant difference between the groups in endometritis, wound infection, UTI or 
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pulmonary infection. The incidence of operative site infection and major infectious 
complications was comparable for LTCD and CCD refuting, according to the authors, the 
widely held belief that women undergoing CCD have a much higher morbidity and mortality 
than those having LTCD.13 Halperin et al. examined 163 classical and 163 low-transverse 
primary CD at 24–35 weeks gestation between 1978 and 1984. Postpartum fever occurred 
significantly more often after a classical CD (16% vs. 6%) than after a LTCD. However, 
more serious complications such as blood loss >1000 mL or need for blood transfusion, 
endometritis, sepsis, wound infection or dehiscence, paralytic ileus, and thromboembolism 
were not significantly different between the 2 groups. Of note, the women in this series 
experienced a relatively high postoperative morbidity (31%).5 Shah et al. studied 178 
women undergoing cesarean delivery (77 CCD and 101 LTCD) for a preterm delivery at a 
single institution between 1983 and 1985 and found that there was no difference in acute 
maternal morbidity (blood loss, infection, and intestinal obstruction) associated with the type 
of uterine incision in the preterm gestation.11
In contrast, there are studies that have shown a difference in maternal morbidity when 
comparing classical to low transverse cesarean delivery. Lao et al. compared 31 women 
delivered by classical CD in a retrospective case-control study to 31 women delivered by 
LTCD between 25 and 34 weeks of gestation. Excluded from the study were women who 
had antepartum hemorrhage or placenta previa. There was a significantly greater reduction 
in maternal hemoglobin and a higher incidence of severe bleeding in the CCD group 
compared to the LTCD group (P < 0.05). The authors concluded that for preterm cesarean 
delivery, the classical incision was associated with increased blood loss compared to the 
lower segment incision.8 In a retrospective study of singleton cesarean delivery between 23–
34 weeks of gestation from 2002–2009 at a single institution, Luthra et el. found an 
increased odds of blood transfusion in 187 CCD compared with 586 LTCD (OR=2.17, 95% 
CI 1.0–4.67).9 Patterson et al. in a 19-year review of all cesarean deliveries in the Nova 
Scotia Atlee Provincial Database (1980–1998) found that puerperal infection, blood 
transfusion, hysterectomy, intensive care unit admission, death) were each significantly 
higher in 221 CCD compared with 19,422 LTCD. However, the mean gestational age at 
delivery was significantly higher in the LTCD group (38.8 weeks of gestation) than the CCD 
group (31.6 weeks of gestation).10 The analyses did not account for indications for delivery 
such as preeclampsia and PPROM which by themselves are associated with increased 
maternal morbidity and are more frequent in preterm deliveries.
Although our study has a larger sample size than previous studies, there are a few 
limitations. With an even larger sample size in our study, the difference in serious maternal 
complications between classical and low transverse cesarean delivery was not statistically 
significant (aRR 1.37, 95% CI 0.95–1.97). This may be due to inadequate sample size. In 
addition, we accounted for baseline characteristics of women (e.g. BMI) as well as 
conditions that would affect maternal outcome such as hypertension in the multivariable 
analyses, but there may have been other conditions present that were not adjusted for that 
could have influenced maternal outcomes.
There are several strengths of this study. The use of trained chart abstractors to obtain 
detailed medical information, uniform and rigorous definitions used for outcomes, and the 
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relatively large sample size of early preterm births compared with previous studies allowed 
for comparison of maternal morbidity by delivery route and gestational age. We excluded 
women with indications for early preterm delivery morbidity (eg accreta, abruption, 
cardiopulmonary collapse) which could be responsible for the increased complications seen 
after delivery to allow for better understanding of the association of delivery route itself with 
maternal morbidity. Furthermore, we were able to adjust for important covariates 
influencing maternal morbidity given the detailed medical record abstraction.
In conclusion, women undergoing an early preterm delivery are at substantially increased 
risk of having a serious maternal complication, particularly in those who undergo cesarean 
delivery. Given the relatively high rates of maternal complications after early preterm 
delivery, obstetricians need to be prepared to manage potential hemorrhage, infection and 
ICU admission. There has been a substantial improvement in neonatal outcomes after early 
preterm delivery. It is time to focus on the concomitant improvement of maternal outcomes 
after early preterm delivery. Determination of the optimal antepartum, intrapartum and 
postpartum management of women who require early preterm delivery will be needed in 
order to decrease the high rates of maternal complications observed.
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Table 2
Serious maternal complications and delivery route, by gestational age at delivery
Outcome, n (%)*








Composite serious maternal complications 67 (11.5) 86 (9.5) 70 (6.3) <.001
  Hemorrhage 41 (7.0) 46 (5.1) 34 (3.1) <.001
  Infection 16 (2.7) 27 (2.9) 15 (1.3) .03
  ICU admission 20 (3.4) 36 (3.9) 33 (2.9) .43
  Death 1 (0.2) 1 (0.1) 0 (0.0) .33
Delivery route <.001
  Classical cesarean (CCD) 154 (25.8) 89 (9.7) 29 (2.5)
  Low transverse cesarean (LTCD) 145 (24.3) 365 (39.7) 394 (34.5)
  Low vertical cesarean (LVCD) 13 (2.2) 10 (1.1) 6 (0.5)
  Vaginal (VD) 285 (47.7) 455 (49.5) 714 (62.5)
*
all 2659 women had complete data to define the outcomes of infection, ICU admission, and death; 63 had missing data to define hemorrhage; 61 
had missing data to define MM
†
based on the chi-square or Fisher’s exact test
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Table 4
Adjusted* relative risk (95%CI) for association between route of delivery and serious maternal complications, 














Overall, 23–33 weeks gestation 3.54 (2.29–5.48) 2.59 (1.77–3.77) 2.27 (0.68–7.55) 1.0 (referent)
  23–27 weeks gestation† 3.22 (1.62–6.38) 2.86 (1.35–6.05) 4.20 (0.90–19.55) 1.0 (referent)
  28–31 weeks gestation† 2.69 (1.39–5.21) 1.86 (1.06–3.26) 1.16 (0.15–8.94) 1.0 (referent)
  32–33 weeks gestation† 8.16 (3.44–19.40) 3.48 (1.91–6.32) ‡ 1.0 (referent)
Bold indicates RR significant at P<.01
*
adjusted for maternal age, race, body mass index, hypertension (chronic, gestational or preeclampsia), diabetes (pregestational or gestational), 
preterm premature rupture of membranes, preterm labor, gestational age at delivery, and hospital
†
based on model with interaction terms; interaction p=.09
‡
not computed due to small cell sizes
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